Cinaciguat

Cinaciguat
Systematic (IUPAC) name
4-({(4-carboxybutyl)[2-(2-{[4-(2-phenylethyl)
phenyl]methoxy}phenyl)ethyl]amino}methyl)
benzoic acid
Clinical data
Routes of
administration
intravenous (?)
Identifiers
CAS Number 329773-35-5 YesY
ATC code none
PubChem CID 9808022
IUPHAR/BPS 5168
ChemSpider 7983781 N
UNII 59K0Y58UAD YesY
Chemical data
Formula C36H39NO5
Molar mass 565.697 g/mol
 NYesY (what is this?)  (verify)

Cinaciguat (BAY 58-2667) is an experimental drug for the treatment of acute decompensated heart failure.

Mechanism of action

Cinaciguat activates the soluble guanylate cyclase (sGC) which is a receptor for nitric oxide. This increases biosynthesis of cyclic GMP, resulting in vasodilation.[1]

See also

References

  1. Schubert-Zsilavecz, M, Wurglics, M, Neue Arzneimittel 2009


This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.